| POLICHEM S.A. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120035124 | USE OF NIFURATEL TO TREAT INFECTIONS CAUSED BY ATOPOBIUM SPECIES - The present invention is directed to the use of nifuratel, or a physiologically acceptable salt thereof, to treat' infections caused by | 02-09-2012 |
| 20110207696 | Compositions for treating rosacea - The present invention is directed to compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, and a short-medium chain dicarboxylic acid amide, or a physiologically acceptable salt thereof, forming a film after application onto the skin, useful for protecting skin of the face and of other affected areas in couperose, rosacea and telangiectasia of the legs. | 08-25-2011 |
| 20110195944 | MODIFIED RELEASE EMULSIONS FOR APPLICATION TO SKIN OR VAGINAL MUCOSA - Modified release oil in water emulsions that delivers drugs to a target tissue. The emulsions according to the present invention contain the lipophilic active ingredient completely dissolved into the hydrophobic internal phase stabilised by a polymeric surfactant. The presence of this polymer around the hydrophobic droplets avoids the migration of the active ingredient into the external hydrophilic phase and, consequently, its re-crystallization. | 08-11-2011 |
| 20110183016 | Film-forming liquid formulations for drug release to hair and scalp - The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, which form a film after application onto the scalp and/or the hair, which compositions are useful for delivery of actives onto the scalp surface and/or onto the hair. | 07-28-2011 |
| 20110091555 | Use of a hydrophilic matrix comprising a polyacrylic acid derivative, a cellulose ether and a disintegrant in the manufacture of a medicament for treating female genital disorders. - A hydrophilic matrix is disclosed which comprises: | 04-21-2011 |
| 20100215780 | Method for treating onychoschizia - The present invention is directed to compositions containing a combination of a herb from the genus | 08-26-2010 |
| 20100152133 | USE OF CHITOSANS TO INCREASE NAIL GROWTH RATE - The present invention is directed to the use of chitosan, a chitosan derivative or a physiologically acceptable salt thereof, to increase nail growth rate. The invention is further directed to the use of chitosans to accelerate nail growth rate during treatment of nail illnesses, nail dystrophy or other nail conditions, in order to shorten considerably the specific treatments of said nail illnesses, nail dystrophy or other nail conditions. | 06-17-2010 |
| 20100104670 | USE OF CHITOSANS FOR THE TREATMENT OF NAIL INFLAMMATORY DISEASES - Chitosan-based nail formulations are useful to treat nail inflammatory diseases like psoriasis, atopic dermatitis and | 04-29-2010 |
| 20100062083 | DERMAL FILM-FORMING LIQUID FORMULATIONS FOR DRUG RELEASE TO SKIN - The present invention is directed to liquid compositions containing chitosan, a chitosan derivative or a physiologically acceptable salt thereof, forming a dermal film after application onto the skin, useful for delivery of actives onto the skin surface and in the stratum corneum. | 03-11-2010 |
| 20100028426 | TIME-SPECIFIC DELAYED/PULSATILE RELEASE DOSAGE FORMS. - A time-specific delayed/pulsatile release dosage form which comprises:
| 02-04-2010 |
| 20090291931 | COMPOSITIONS WITH ENHANCED ELASTICIZING ACTIVITY - Compositions for improving the elasticity of the vagina and of the perineum during the last trimester of pregnancy, include combining a thiolated compound or mixture thereof with an ester of organic acid or mixture thereof. The compositions according to the present invention improve the elastic properties of the vaginal and/or perineal tissues in terms both of increased extensibility and faster elastic recovery. The compositions according to the present invention may decrease risk of trauma of perineal tissues during delivery, as well as risk of rectal or bladder incontinence as a post-partum short/medium/long term complication. | 11-26-2009 |
| 20090035361 | Composition for vaginal use - Compositions for vaginal use comprising lupulus ( | 02-05-2009 |
